Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2003, p. 3392-3404, Vol. 23, No. 10
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.10.3392-3404.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado 80523-1870,1 Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 212052
Received 21 October 2002/ Returned for modification 3 December 2002/ Accepted 4 March 2003
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
CBP and p300 are very large paralogous proteins that coordinate highly regulated gene expression in metazoans. Several conserved domains in CBP and p300 serve as binding sites for a wide variety of structurally unrelated cellular and viral transcription factors. These domains in CBP/p300 include two cysteine-histidine-rich domains (CH1 and CH3), the SRC-interacting domain, and the KIX domain (for recent reviews, see references 11 and 21). The transcription factor-coactivator interactions mediated by these domains facilitate recruitment of the coactivators to target promoters. Subsequent to recruitment by the transcription factors, CBP and p300 appear to stimulate transcription through multiple, distinct mechanisms. For example, there is evidence that CBP/p300 may directly stabilize components of the general transcription machinery at target promoters (13, 40). Additionally, CBP and p300 have intrinsic acetyltransferase activity that targets multiple lysine residues present on the four core histone tails (8, 51). A significant body of evidence suggests that histone tail acetylation weakens internucleosomal interactions, which may lead to a more relaxed chromatin structure, providing greater transcription factor or RNA polymerase access at target promoters (5, 17, 24). Additionally, combinations of differentially acetylated histone tails may serve as recognition sites for the assembly of factors that facilitate transitions from transcriptionally silent to transcriptionally active chromatin (30, 60). Although the evidence for histone acetylation by CBP/p300 is strong, the precise mechanistic events that couple transcriptional activation with acetylation of promoter-proximal nucleosomes are unknown.
The HTLV-1 Tax protein has previously been shown to bind at three of the four major transcription factor interaction domains in CBP/p300: CH1, KIX, and the carboxy-terminal SRC-interacting domain (19, 26, 39, 42, 58, 65). The interaction between Tax and KIX has been studied in the greatest detail and is the only Tax-CBP/p300 interaction that has been reported to occur with the Tax-containing, promoter-bound ternary complex (Tax/CREB/viral CRE DNA) (19, 26, 39, 65). This observation suggests that the ternary complex interaction with KIX may play a major role in CBP/p300 recruitment to the HTLV-1 promoter. However, little is known about the functional significance of this protein-protein interaction.
In this study, we explore the transcriptional relevance of the Tax-KIX interaction in Tax transactivation from chromatin-assembled templates in vitro. Using polypeptides specifically designed to inhibit CBP/p300 association with the Tax/CREB/viral CRE complex, we demonstrate that the KIX domain of CBP/p300 is critical for mediating coactivator function at the HTLV-1 promoter. The inhibition is specific to Tax transactivation on chromatin templates and, unexpectedly, is independent of the four core histone amino-terminal tails. We extend these studies to examine the contribution of the acetyltransferase function of the coactivators on Tax transactivation from the HTLV-1 promoter. We find that the CBP/p300-selective acetyltransferase inhibitor Lys-coenzyme A (CoA) inhibits Tax transactivation from chromatin templates to the same levels observed with the polypeptide inhibitors. These observations indicate that CBP and p300 play a prominent role in Tax transactivation from chromatin templates and that the acetyltransferase activity of the coactivators provides the major functional contribution to transcriptional activation in vitro. Interestingly, a strong CBP/p300-specific acetyltransferase requirementwas also observed on chromatin templates prepared from tailless histones. We identify multiple nonhistone acetylation targets, a subset of which are dependent upon Tax and CREB. Together, these data indicate that CBP and p300 participate in critical chromatin-specific, tail-independent acetylation events during transcriptional activation by Tax.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1-12 and
119-128), H2B (
1-23), H3 (
1-26), and H4 (
1-19). Drosophila NAP-1 (28), ISWI, and Acf1 (29) were expressed and purified as previously described (18). Full-length, recombinant CREB (16) and Tax (68) were expressed and purified as previously described (19). Six-histidine (His6)-tagged p300 was expressed and purified as previously described (37). Recombinant glutathione S-transferase (GST) and the GST fusion proteins GST-KIX (CBP amino acids [aa] 588 to 683) (19), GST-KIXmut (CBP aa 597 to 719) (65), and GST-SREBP-1a (SREBP-1 aa 1 to 50) (50) were expressed and purified as previously described. Chromatin assembly and in vitro transcription. Chromatin templates were assembled as previously described at core histone/DNA ratios that were empirically determined to give complete chromatin assembly (18). The 3.2-kbp p4TxRE/G-less plasmid DNA used in the transcription assays carried four tandem copies of the HTLV-1 promoter-proximal viral CRE cloned upstream of the HTLV-1 core promoter and drove the synthesis of a 380-nucleotide (nt) transcript (4). The p-52/G-less plasmid DNA carried positions -52 to +1 (relative to the transcription start site) of the natural HTLV-1 core promoter and drove the synthesis of a 190-nt transcript (4). This plasmid contained a TATA box but no Tax-responsive viral CRE sequences. Following chromatin assembly, 75 fmol of the chromatin-assembled template was incubated in the absence or presence of 80 nM purified recombinant Tax, 80 nM CREB, 3 nM p300, and 40 µg of CEM (HTLV-1-negative human T-lymphocyte) nuclear extract, as previously described (18, 43). For experiments using unassembled or naked DNA templates, samples were prepared as described above, but without the chromatin assembly step. All reaction mixtures contained 100 µM acetyl-CoA unless otherwise indicated. Molecular weight markers (radiolabeled HpaII-digested pBR322) were used to estimate the size of the RNA products.
Biotin-streptavidin DNA pull-down assay. Double-stranded DNA fragments containing a single viral CRE (and biotinylated at the 5'-end of one strand, [Integrated DNA Technologies]) were annealed and bound to streptavidin-agarose (Novagen) in TM buffer (50 mM Tris, 100 mM KCl, 12.5 mM MgCl2, 1 mM EDTA, 20% glycerol, 0.1% Tween 20, 2 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonyl fluoride [PMSF]). The HTLV-1 promoter-proximal viral CRE sequence used in this assay was modified to contain a consensus CRE site to enhance CREB binding. The sequence of the DNA fragment is 5'-GAAGATCTCTCAGGCGTTGACGTCAACCCCTCACCAGATCTT-3'. The core CRE region is indicated in boldface, and the conserved GC-rich flanks are underlined. The immobilized viral CRE DNA (2 pmol) was incubated with Tax (10 pmol), protein kinase A-phosphorylated CREB (10 pmol), p300 (10 pmol), GST-KIX or GST-KIXmut (5 or 10 pmol), and GST-SREBP-1a or GST (10 or 50 pmol) as indicated in the relevant figures. The reaction mixtures were incubated in binding buffer (25 mM Tris, 50 mM KCl, 6.25 mM MgCl2, 0.5 mM EDTA, 10% glycerol, 0.05% Tween 20, 50 mM NaCl, 2 mM DTT, 1 mM PMSF) for 1 h at 4°C, washed three times in binding buffer, resuspended in sodium dodecyl sulfate (SDS) sample dyes, boiled, and analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (5 to 20% polyacrylamide). Bound proteins were detected by Western blot analysis with a mixture of anti-GST (to detect GST-KIX, GST-KIXmut, GST, and GST-SREBP-1a; Sigma), anti-His6 (to detect Tax and p300; Santa Cruz Biotechnology), and anti-CREB (Santa Cruz Biotechnology) antibodies.
GST pull-down assay. The GST pull-down assay was performed by incubating 10 pmol of GST or GST-SREBP-1a with 15 µl of swollen glutathione-agarose (Sigma) in 400 µl of 0.5x Superdex buffer (12.5 mM HEPES [pH 7.9], 6.25 mM MgCl2, 75 mM KCl, 5 µM ZnSO4, 0.5 mM EDTA, 10% glycerol, 0.05% NP-40) at 4°C for 2 h. The beads were then washed twice with 0.5x Superdex buffer and incubated with 2 pmol of p300 (in a total volume of 400 µl of 0.5x Superdex buffer) at 4°C for 18 h. After being washed twice with 0.5x Superdex, the beads were resuspended in SDS sample dyes, boiled, and analyzed by SDS-PAGE (5 to 20% polyacrylamide). Bound protein was detected by Western blot analysis with an antibody against p300 (N-15; Santa Cruz Biotechnology).
In vitro acetylation assay. The p4TxRE/G-less plasmid template was assembled into chromatin by using wild-type Xenopus histones (2 µg), or tailless Xenopus histones (6 µg), NAP-1, and ACF as previously described (18). Chromatin assembly was performed at empirically determined histone/DNA mass ratios; for samples containing tailless chromatin, this resulted in a 30% larger amount of template than that in the wild-type chromatin samples. However, the amounts of recombinant proteins and nuclear extract that were subsequently added remained constant for all samples. p300 (12 nM) and [14C]acetyl-CoA (0.09 mM; 57 mCi/mmol) were added following chromatin assembly, together with 400 nM Tax and CREB where applicable, in a solution containing 50 mM Tris (pH 8), 10% glycerol, 10 mM sodium butyrate, 1 mM DTT, and 1 mM PMSF. Samples were incubated at 30°C for 60 min, and protein was precipitated by methanol-chloroform extraction and analyzed by SDS-PAGE (18% polyacrylamide). For the acetylation assays using purified chromatin templates, chromatin assembly was carried out as described above, and templates were preincubated for 60 min at 30°C with 12 nM p300, 400 nM Tax, 400 nM CREB, and 400 µg of CEM nuclear extract, where indicated. Following preincubation, samples were fractionated by Sephacryl 200 chromatography, and the void volume eluate, which contained the chromatin template (and associated proteins), was collected. The samples were then incubated with [14C]acetyl-CoA (0.09 mM; 57 mCi/mmol) as described above. Proteins were precipitated by methanol-chloroform extraction and analyzed by SDS-PAGE (5 to 20% polyacrylamide).
| RESULTS |
|---|
|
|
|---|
|
|
|
To directly test whether KIX blocks p300 recruitment to Tax/CREB/viral CRE complexes, we performed a biotin-streptavidin-agarose DNA pull-down assay using an immobilized DNA fragment carrying a single viral CRE binding site for the Tax/CREB complex. We used a naked DNA fragment in this assay, since p300 has previously been shown to interact directly with chromatin (49). As shown in Fig. 3D, full-length p300 forms a quaternary complex with Tax and CREB on the viral CRE DNA (lane 3). Addition of GST-KIX to the binding reaction displaced p300 from the complex in a dose-dependent fashion (Fig. 3D, lanes 3 to 5). Displacement of p300 from the Tax/CREB/DNA complex likely occurred as a consequence of GST-KIX binding, because GST-KIX association with the DNA-bound fraction correlated directly with p300 dissociation (Fig. 3D, lanes 3 to 5). As expected, GST-KIXmut was unable to compete with p300 for binding to the Tax/CREB/DNA complex (Fig. 3D, lanes 6 and 7). The results of SDS-PAGE showing purified GST-KIX and GST-KIXmut used in these assays are presented in Fig. 3E. Together, these data support a model in which KIX inhibits Tax/CREB/p300-mediated transcription via disruption of CBP/p300 binding to the Tax/CREB/viral CRE DNA complex (Fig. 2A).
Although the KIX peptide repression data shown above are consistent with inhibition of CBP/p300 recruitment, it is also possible that the tight binding of KIX to the Tax/CREB complex simply blocks access of another coactivator or ancillary factor to the HTLV-1 promoter. To more specifically define a role for CBP/p300 in Tax transactivation, we next tested whether the addition of purified GST-SREBP-1a could similarly inhibit activated transcription from the chromatin-assembled HTLV-1 promoter. Since SREBP-1a binds directly to the CBP/p300 KIX domain, it is a highly specific inhibitor of KIX function (50). Figure 4A shows that addition of GST-SREBP-1a to the chromatin-based transcription reactions inhibited both Tax/CREB-activated transcription (lanes 2 to 4) and Tax/CREB/p300-activated transcription (lanes 6 to 8). GST-SREBP-1a-mediated transcriptional inhibition was weaker in the presence of exogenously added p300 (Fig. 4A, lanes 6 to 8), consistent with the idea that saturation of CBP/p300 KIX domain is required. Since SREBP-1a was expressed as a GST fusion, we used GST alone as a negative control. GST had no effect on Tax/CREB- or Tax/CREB/p300-activated transcription (Fig. 4A, lanes 5 and 9). Similar to our observation with the GST-KIX polypeptide, addition of GST-SREBP-1a or GST alone had minimal effect on Tax/CREB-activated transcription on naked templates (Fig. 4B). Finally, the addition of GST-SREBP-1a to immobilized biotin-streptavidin DNA pull-down reaction mixtures containing Tax, CREB, p300, and the viral CRE DNA inhibited p300 association with the Tax/CREB/DNA complex in a dose-dependent fashion (Fig. 4C). Unlike KIX, SREBP-1a did not replace p300 in the Tax/CREB/viral CRE DNA complex (data not shown), consistent with our model for SREBP-1a inhibition (Fig. 2B). The purified GST-SREBP-1a and GST used in these experiments are shown in Fig. 4D. The SREBP-1a used in these experiments was functional for binding to full-length p300, as shown by a GST pull-down assay (Fig. 4E).
|
We next examined the specificity of KIX and SREBP-1a function by performing a p300 "add-back" experiment. We reasoned that if KIX and SREBP-1a inhibited transcription by blocking Tax/CREB access to the coactivator, then addition of exogenous p300 would overcome the observed effect. Figure 5 shows that the GST-KIX inhibition was modestly relieved by the addition of recombinant p300 (lanes 5 and 6). However, GST-SREBP-1a inhibition was fully reversed in the presence of the largest amount of added coactivator (Fig. 5, lane 9). This difference in the degree of transcriptional response to exogenous p300 in the presence of KIX and SREBP-1a is not unexpected, because the two polypeptides mediate transcriptional inhibition via distinct mechanisms (Fig. 2). It is possible that a slow off-rate of GST-KIX from the Tax/CREB complex inhibits access to the exogenous p300. Alternatively, SREBP-1a transcriptional inhibition likely occurs via direct stoichiometric binding to endogenous CBP/p300; therefore, the excess p300 should be available for recruitment to the Tax/CREB/viral CRE complex.
|
To specifically evaluate the contribution of endogenous acetyltransferase activity in our transcription system, we tested the effect of the selective CBP/p300 inhibitor Lys-CoA on Tax/CREB-activated transcription. Lys-CoA has previously been shown to inhibit p300 (and by extension CBP) both in vitro and in vivo, with a >100-fold selectivity for p300 relative to P/CAF (6, 38, 41, 45, 54). Figure 6A shows that the addition of 50 µM Lys-CoA to Tax-activated chromatin transcription reaction mixtures containing 10 µM acetyl-CoA reduced RNA synthesis by >90% (lane 4), consistent with a previous observation (46). The concentrations of Lys-CoA used in these experiments have previously been shown to selectively inhibit p300 acetyltransferase activity by >90% (41). We next tested Lys-CoA inhibition in the presence of Tax/CREB and exogenous p300 and found that Lys-CoA inhibited transcription to a degree similar to that observed with Tax/CREB alone (Fig. 6B, lanes 4 and 5). As expected, Tax/CREB/p300-activated transcription was essentially abolished in the absence of acetyl-CoA (Fig. 6B, lane 6). Lys-CoA had minimal effect on Tax/CREB-activated transcription from naked DNA templates (Fig. 6C).
|
|
1-12 and
119-128, H2B
1-23, H3
1-26, and H4
1-19) to assemble chromatin on the p4TxRE/G-less template as previously described (18). All of the previously identified targets of CBP/p300 acetylation are deleted in our tailless histones (57). We tested whether chromatin composed of tailless histones was sensitive to KIX/SREBP-1a inhibition of Tax/CREB-mediated transcriptional activation. As shown before, nucleosomal templates formed with tailless histones were strongly activated by Tax/CREB and insensitive to exogenous p300 (Fig. 8A, lanes 1 to 3) (18). Unexpectedly, the addition of GST-KIX, but not GST-KIXmut, inhibited Tax/CREB transcriptional activation over 80% on the tailless templates (Fig. 8A, lanes 4 to 7). Similar transcriptional inhibition was observed with GST-SREBP-1a, in both the presence and absence of exogenous p300 (Fig. 8B). These results were surprising, because the tailless histones carry deletions of the regions encompassing the previously characterized sites of acetylation. We confirmed the specificity of the effects of KIX and SREBP-1a on tailless chromatin by performing a p300 "add-back" experiment (Fig. 8C). Consistent with the results for wild-type chromatin templates (Fig. 5), we found that inhibition by GST-KIX is highly stable and is not responsive to exogenous p300, while inhibition by GST-SREBP-1a was reversed by exogenous p300. To determine if KIX- and SREBP-1a-mediated transcriptional inhibition was associated with disrupted recruitment of the acetyltransferase activity of CBP/p300, we tested the effect of Lys-CoA on Tax-activated transcription from the tailless chromatin templates. Figure 8D shows that 50 µM Lys-CoA inhibited transcription by up to 80%. Interestingly, this effect was indistinguishable from the level of inhibition observed in the absence of acetyl-CoA, suggesting that acetyl-CoA is utilized exclusively by CBP/p300 on these templates. Together, these data strongly support a role for CBP/p300 acetyltransferase activity in Tax/CREB-dependent activation of transcription from tailless nucleosomal templates.
|
|
| DISCUSSION |
|---|
|
|
|---|
We also investigated the specific role of the intrinsic acetyltransferase activity of CBP/p300 in Tax transactivation. As previously shown, we find that Tax enhances nucleosomal histone acetylation by recruiting p300 to chromatin templates (18, 45). We find that the addition of KIX peptide dramatically inhibits this effect, directly coupling Tax recruitment of CBP/p300, via the KIX domain, with nucleosome acetylation and transcriptional activation. We find that the p300-selective inhibitor Lys-CoA significantly blocks Tax-activated transcription, reducing transcription to the same levels observed with the KIX-specific polypeptide inhibitors. This observation is consistent with a prominent role for a CBP/p300 acetyltransferase activity in transcriptional initiation, as previously suggested (36, 38). Additionally, a recent study has shown that a p300 acetyltransferase mutant was unable to activate transcription from the integrated HTLV-1 promoter in vivo (52). These data provide further evidence that CBP and p300 are the prominent coactivators mediating Tax transcription function and, importantly, that the acetyltransferase activity intrinsic to CBP/p300 provides the dominant transcriptional stimulatory activity associated with coactivator recruitment to the Tax-responsive promoter.
Although we observe residual Tax transactivation in the presence of Lys-CoA, transcription is abolished in the absence of acetyl-CoA. While this may represent incomplete Lys-CoA inhibition of endogenous CBP/p300, it is also possible that acetyltransferases unrelated to CBP/p300 participate in Tax transactivation from chromatin templates. This observation is not surprising, because a broad range of coactivators and ancillary factors utilize acetyl-CoA to activate transcription (59). These additional coactivators may include proteins that acetylate lysine residues on the core histone amino-terminal tails that are distinct from those lysines targeted by CBP/p300. These proteins may also include acetyltransferases that cooperate with CBP/p300. For example, lysine 14 of histone H3 is acetylated not only by CBP/p300, but also by GCN5, P/CAF, and TAFII250 (59). Of these acetyltransferases, P/CAF has been shown to interact with Tax in both vitro and in vivo and to activate HTLV-1 transcription in transient transfection assays (25, 31). It is possible that P/CAF cooperates with CBP/p300 in histone tail acetylation and thus participates in Tax transactivation of HTLV-1 transcription.
We previously reported that the amino-terminal histone tails are required for Tax transactivation in response to exogenously added p300 and that tail deletion rendered the chromatin templates insensitive to recombinant p300 addition, while remaining moderately sensitive to acetyl-CoA (18). In the previous study, however, the role of endogenous CBP/p300 in Tax transactivation was not addressed. In the present study, we make the unexpected observation that the acetyltransferase activity required for Tax transactivation on the tailless chromatin templates is contributed by CBP/p300 present in the nuclear extract. We observe potent inhibition of Tax-activated transcription from the tailless chromatin templates with both Lys-CoA and the polypeptide inhibitors. Interestingly, Lys-CoA inhibits transcription to the same level as that observed in the absence of acetyl-CoA. These data indicate that CBP/p300 play a prominent and perhaps exclusive role in Tax transactivation from tailless chromatin templates and that the acetyltransferase activity provides the coactivator function in this context.
It seems paradoxical that tailless chromatin templates require CBP/p300 acetyltransferase activity and yet are unresponsive to exogenous p300. However, responsiveness to exogenous p300 may be a function of the number of potential acetylation sites present in the transcription system. For example, previous characterization of CBP/p300 suggests that wild-type chromatin templates contain up to 22 CBP/p300 acetylation targets per nucleosome, in addition to other potential CBP/p300 acetyltransferase targets present in the nuclear extract (57). Although we have found a substantial concentration of endogenous CBP/p300 in our CEM nuclear extract, it appears that the endogenous CBP/p300 may be limiting. Therefore, Tax transactivation from wild-type chromatin templates is enhanced by exogenous p300. However, in the absence of histone tails, the number of potential CBP/p300 acetylation substrates present in the transcription system is dramatically reduced. Therefore, endogenous CBP/p300 acetyltransferase activity may be saturating for strong Tax transactivation from tailless chromatin templates; consequently, exogenous p300 has no effect. Consistent with the idea that a reduced number of acetylation substrates leads to a reduced requirement for acetyltransferase enzyme, we have previously observed that tailless chromatin templates have a reduced requirement for acetyl-CoA in Tax transactivation compared with that of wild-type chromatin templates (18; data herein).
In vitro acetylation assays of transcription complexes formed on tailless chromatin templates revealed the presence of CBP/p300-specific acetylation targets that are histone tail independent. These unidentified acetylation targets may be components of the general transcription machinery and/or chromatin remodeling factors that are acetylated to facilitate negotiation of chromatin templates during transcriptional activation. In recent years, the collective work of many groups has produced an impressive list of non-histone CBP/p300 substrates. These include HMG proteins, the general transcription factors TFIIE and TFIIF, various transcriptional activators, and proteins involved in nuclear import (reviewed in reference 59). Our data also suggest that Tax, and/or CREB, may be acetylated by CBP/p300. Whether these transcriptional activators are bona fide acetylation substrates for CBP/p300 and whether acetylation has any effect on their function is not known. The role of these known and unknown CBP/p300 acetylation substrates in Tax transactivation remains to be elucidated.
Another intriguing possibility is that the nucleosomal core is itself acetylated by CBP/p300. Recent studies indicate that histones can be modified at lysine residues in regions other than the well-characterized amino-terminal tails (14, 56, 61, 63). In the experiments presented herein, we used a histone H3 deletion mutant that carried a lysine residue at the amino-terminal end of the protein (corresponding to aa 27). Although lysine 27 may be acetylated in yeast (33), it is not one of the previously identified CBP/p300 acetylation targets (57). It is a formal possibility that this lysine residue is acetylated by CBP/p300, because we observe tailless H3 acetylation on chromatin templates. However, when these templates were incubated with nuclear extract, the acetylated H3 band was not readily discernible. It is therefore equivocal whether acetylation within the globular domain of histone H3 plays a role in transcriptional activation.
While our observation of strong transcriptional activation from chromatin templates assembled with tailless histones is in contrast to a recently published study (2), it is consistent with a number of previous studies showing that tailless chromatin templates are more accessible to binding by transcriptional activators (20, 53, 64) and are generally more transcriptionally active than intact chromatin templates (12, 27, 55, 64). This may reflect the ability of tailless chromatin to adopt a less-condensed structure than intact chromatin (10, 15, 35, 62; reviewed in reference 23). The fact that both our wild-type and tailless chromatin templates respond similarly to Tax transactivation suggests that histone acetylation and histone tail deletion are functionally equivalent at the HTLV-1 promoter.
In summary, the data presented in this study demonstrate a prominent and perhaps exclusive role for the KIX domain in CBP/p300 recruitment by the HTLV-1 Tax protein. We find that Tax transactivation from chromatin templates is largely dependent upon CBP/p300 present in the nuclear extract and that the acetyltransferase activity is the prominent functional property of the coactivators responsible for mediating transcriptional activation. By specifically inhibiting CBP/p300 enzymatic activity in transcription from tailless chromatin templates, we have discovered a mode of CBP/p300 transcriptional regulatory function that is acetyl-CoA dependent and histone tail independent. We find that CBP/p300 acetyltransferase activity may not be directed at the histone tails, but instead at undefined targets whose acetylation is critical to the activation of viral gene expression in a chromatin context. Our data provide insight into a novel mechanism of HTLV-1 transcriptional regulation by CBP/p300 that may have broad implications for CBP/p300 function.
| ACKNOWLEDGMENTS |
|---|
This study was supported by National Institutes of Health grants CA87540 to J.K.N. and P.J.L. and GM62437 to P.A.C.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. An, W., V. B. Palhan, M. A. Karymov, S. H. Leuba, and R. G. Roeder. 2002. Selective requirements for histone H3 and H4 N termini in p300-dependent transcriptional activation from chromatin. Mol. Cell 9:811-821.[CrossRef][Medline]
3. An, W., and R. G. Roeder. 2003. Direct association of p300 with unmodified H3 and H4 N termini modulates p300-dependent acetylation and transcription of nucleosomal templates. J. Biol. Chem. 278:1504-1510.
4. Anderson, M. G., K. E. S. Scoggin, C. M. Simbulan-Rosenthal, and J. A. Steadman. 2000. Identification of poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein. J. Virol. 74:2169-2177.
5. Annunziato, A. T., and J. C. Hansen. 2000. Role of histone acetylation in the assembly and modulation of chromatin structures. Gene Expr. 9:37-61.[Medline]
6. Asahara, H., B. Santoso, E. Guzman, K. Du, P. A. Cole, I. Davidson, and M. Montminy. 2001. Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol. Cell. Biol. 21:7892-7900.
7. Asahara, H., S. Tartare-Deckert, T. Nakagawa, T. Ikehara, F. Hirose, T. Hunter, T. Ito, and M. Montminy. 2002. Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro. Mol. Cell. Biol. 22:2974-2983.
8. Bannister, A. J., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.[CrossRef][Medline]
9. Bex, F., M.-J. Yin, A. Burny, and R. B. Gaynor. 1998. Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol. Cell. Biol. 18:2392-2405.
10. Carruthers, L. M., and J. C. Hansen. 2000. The core histone N termini function independently of linker histones during chromatin condensation. J. Biol. Chem. 275:37285-37290.
11. Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
12. Chirinos, M., F. Hernandez, and E. Palacian. 1998. Repressive effect on oligonucleosome transcription of the core histone tail domains. Biochemistry 37:7251-7259.[CrossRef][Medline]
13. Dallas, P. B., P. Yaciuk, and E. Moran. 1997. Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J. Virol. 71:1726-1731.[Abstract]
14. Dover, J., J. Schneider, M. A. Boateng, A. Wood, K. Dean, M. Johnston, and A. Shilatifard. 2002. Methylation of histone H3 by COMPASS requires ubiquitination of histone H2B by RAD6. J. Biol. Chem. 17:28368-28371.
15. Fletcher, T. M., and J. C. Hansen. 1995. Core histone tail domains mediate oligonucleosome folding and nucleosomal DNA organization through distinct molecular mechanisms. J. Biol. Chem. 270:25359-25362.
16. Franklin, A. A., M. F. Kubik, M. N. Uittenbogaard, A. Brauweiler, P. Utaisincharoen, M. A. Matthews, W. S. Dynan, J. P. Hoeffler, and J. K. Nyborg. 1993. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2), ATF-2 response and cAMP element-binding protein (CREB). J. Biol. Chem. 268:21225-21231.
17. Garcia-Ramirez, M., C. Rocchini, and J. Ausio. 1995. Modulation of chromatin folding by histone acetylation. J. Biol. Chem. 270:17923-17928.
18. Georges, S. A., W. L. Kraus, K. Luger, J. K. Nyborg, and P. J. Laybourn. 2002. p300-mediated Tax transactivation from recombinant chromatin: histone tail deletion mimics coactivator function. Mol. Cell. Biol. 22:127-137.
19. Giebler, H. A., J. E. Loring, K. van Orden, M. A. Colgin, J. E. Garrus, K. W. Escudero, A. Brauweiler, and J. K. Nyborg. 1997. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol. Cell. Biol. 17:5156-5164.[Abstract]
20. Godde, J. S., Y. Nakatani, and A. P. Wolffe. 1995. The amino-terminal tails of the core histones and the translational position of the TATA box determine TBP/TFIIA association with nucleosomal DNA. Nucleic Acids Res. 23:4557-4564.
21. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
22. Goren, I., O. J. Semmes, K.-T. Jeang, and K. Moelling. 1995. The amino terminus of Tax is required for interaction with the cyclic AMP response element binding protein. J. Virol. 69:5806-5811.[Abstract]
23. Hansen, J. C. 2002. Conformational dynamics of the chromatin fiber in solution: determinants, mechanisms, and functions. Annu. Rev. Biophys. Biomol. Struct. 31:361-392.[CrossRef][Medline]
24. Hansen, J. C., C. Tse, and A. P. Wolffe. 1998. Structure and function of the core histone N-termini: more than meets the eye. Biochemistry 37:17637-17641.[CrossRef][Medline]
25. Harrod, R., Y. L. Kuo, Y. Tang, Y. Yao, A. Vassilev, Y. Nakatani, and C. Z. Giam. 2000. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J. Biol. Chem. 275:11852-11857.
26. Harrod, R., Y. Tang, C. Nicot, H. S. Lu, A. Vassilev, Y. Nakatani, and C.-Z. Giam. 1998. An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol. Cell. Biol. 18:5052-5061.
27. Hernandez, F., L. Lopez-Alarcon, C. Puerta, and E. Palacian. 1998. Transcriptional inhibitory role of the tail domains of histone (H3 x H4)2 tetramers. Arch. Biochem. Biophys. 358:98-103.[CrossRef][Medline]
28. Ito, T., M. Bulger, R. Kobayashi, and J. T. Kadonaga. 1996. Drosophila NAP-1 is a core histone chaperone that functions in ATP-facilitated assembly of regularly spaced nucleosomal arrays. Mol. Cell. Biol. 16:3112-3124.[Abstract]
29. Ito, T., M. E. Levenstein, D. V. Fyodorov, A. K. Kutach, R. Kobayashi, and J. T. Kadonaga. 1999. ACF consists of two subunits, Acf1 and ISWI, that function cooperatively in the ATP-dependent catalysis of chromatin assembly. Genes Dev. 13:1529-1539.
30. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074-1080.
31. Jiang, H., H. Lu, R. L. Schiltz, C. A. Pise-Masison, V. V. Ogryzko, Y. Nakatani, and J. N. Brady. 1999. PCAF interacts with Tax and stimulates Tax transactivation in a histone acetyltransferase-independent manner. Mol. Cell. Biol. 19:8136-8145.
32. Kashanchi, F., J. F. Duvall, R. P. Kwok, J. R. Lundblad, R. H. Goodman, and J. N. Brady. 1998. The coactivator CBP stimulates human T-cell lymphotrophic virus type I Tax transactivation in vitro. J. Biol. Chem. 273:34646-34652.
33. Kelly, T. J., S. Qin, D. E. Gottschling, and M. R. Parthun. 2000. Type B histone acetyltransferase Hat1p participates in telomeric silencing. Mol. Cell. Biol. 20:7051-7058.
34. Kimzey, A. L., and W. S. Dynan. 1998. Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking. J. Biol. Chem. 273:13768-13775.
35. Krajewski, W. A., and J. Ausio. 1996. Modulation of the higher-order folding of chromatin by deletion of histone H3 and H4 terminal domains. Biochem. J. 316:395-400.
36. Kraus, W. L., and J. T. Kadonaga. 1998. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12:331-342.
37. Kraus, W. L., E. T. Manning, and J. T. Kadonaga. 1999. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol. Cell. Biol. 19:8123-8135.
38. Kundu, T. K., V. B. Palhan, Z. Wang, W. An, P. A. Cole, and R. G. Roeder. 2000. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell 6:551-561.[CrossRef][Medline]
39. Kwok, R. P., M. E. Laurance, J. R. Lundblad, P. S. Goldman, H. Shih, L. M. Connor, S. J. Marriott, and R. H. Goodman. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642-646.[CrossRef][Medline]
40. Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bachinger, R. G. Brennan, S. G. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226.[CrossRef][Medline]
41. Lau, O. D., T. K. Kundu, R. E. Soccio, S. Ait-Si-Ali, E. M. Khalil, A. Vassilev, A. P. Wolffe, Y. Nakatani, R. G. Roeder, and P. A. Cole. 2000. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol. Cell 5:589-595.[CrossRef][Medline]
42. Lemasson, I., and J. K. Nyborg. 2001. Human T-cell leukemia virus type I Tax repression of p73beta is mediated through competition for the C/H1 domain of CBP. J. Biol. Chem. 276:15720-15727.
43. Lenzmeier, B. A., E. E. Baird, P. B. Dervan, and J. K. Nyborg. 1999. The tax protein-DNA interaction is essential for HTLV-I transactivation in vitro. J. Mol. Biol. 291:731-744.[CrossRef][Medline]
44. Lenzmeier, B. A., H. A. Giebler, and J. K. Nyborg. 1998. Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol. Cell. Biol. 18:721-731.
45. Lu, H., C. A. Pise-Masison, T. M. Fletcher, R. L. Schiltz, A. K. Nagaich, M. Radonovich, G. Hager, P. A. Cole, and J. N. Brady. 2002. Acetylation of nucleosomal histones by p300 facilitates transcription from Tax-responsive human T-cell leukemia virus type 1 chromatin template. Mol. Cell. Biol. 22:4450-4462.
46. Luger, K., T. J. Rechsteiner, A. J. Flaus, M. M. Waye, and T. J. Richmond. 1997. Characterization of nucleosome core particles containing histone proteins made in bacteria. J. Mol. Biol. 272:301-311.[CrossRef][Medline]
47. Luger, K., T. J. Rechsteiner, and T. J. Richmond. 1999. Preparation of nucleosome core particle from recombinant histones. Methods Enzymol. 304:3-19.[Medline]
48. Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. S. Huang, J. P. Richards, R. G. Brennan, and R. H. Goodman. 1998. The human T-cell leukemia virus-1 transcriptional activator Tax enhances cAMP-responsive element-binding protein (CREB) binding activity through interactions with the DNA minor groove. J. Biol. Chem. 273:19251-19259.
49. Manning, E. T., T. Ikehara, T. Ito, J. T. Kadonaga, and W. L. Kraus. 2001. p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol. Cell. Biol. 21:3876-3887.
50. Naar, A. M., P. A. Beaurang, K. M. Robinson, J. D. Oliner, D. Avizonis, S. Scheek, J. Zwicker, J. T. Kadonaga, and R. Tjian. 1998. Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro. Genes Dev. 12:3020-3031.
51. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.[CrossRef][Medline]
52. Okada, M., and K.-T. Jeang. 2002. Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J. Virol. 76:12564-12573.
53. Polach, K. J., P. T. Lowary, and J. Widom. 2000. Effects of core histone tail domains on the equilibrium constants for dynamic DNA site accessibility in nucleosomes. J. Mol. Biol. 298:211-223.[CrossRef][Medline]
54. Polesskaya, A., I. Naguibneva, L. Fritsch, A. Duquet, S. Ait-Si-Ali, P. Robin, A. Vervisch, L. L. Pritchard, P. Cole, and A. Harel-Bellan. 2001. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20:6816-6825.[CrossRef][Medline]
55. Protacio, R. U., G. Li, P. T. Lowary, and J. Widom. 2000. Effects of histone tail domains on the rate of transcriptional elongation through a nucleosome. Mol. Cell. Biol. 20:8866-8878.
56. Robzyk, K., J. Recht, and M. A. Osley. 2000. Rad6-dependent ubiquitination of histone H2B in yeast. Science 287:501-504.
57. Schiltz, R. L., C. A. Mizzen, A. Vassilev, R. G. Cook, C. D. Allis, and Y. Nakatani. 1999. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274:1189-1192.
58. Scoggin, K. E. S., A. Ulloa, and J. K. Nyborg. 2001. The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol. Cell. Biol. 21: